These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 1710248

  • 1. An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection.
    Posner MR, Hideshima T, Cannon T, Mukherjee M, Mayer KH, Byrn RA.
    J Immunol; 1991 Jun 15; 146(12):4325-32. PubMed ID: 1710248
    [Abstract] [Full Text] [Related]

  • 2. Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization.
    Cavacini LA, Emes CL, Power J, Duval M, Posner MR.
    J Immunol; 1994 Mar 01; 152(5):2538-45. PubMed ID: 7510748
    [Abstract] [Full Text] [Related]

  • 3. Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody.
    Cavacini LA, Emes CL, Power J, Desharnais FD, Duval M, Montefiori D, Posner MR.
    J Immunol; 1995 Oct 01; 155(7):3638-44. PubMed ID: 7561063
    [Abstract] [Full Text] [Related]

  • 4. A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event.
    McInerney TL, McLain L, Armstrong SJ, Dimmock NJ.
    Virology; 1997 Jul 07; 233(2):313-26. PubMed ID: 9217055
    [Abstract] [Full Text] [Related]

  • 5. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L, Zolla-Pazner S, Gorny MK, Cheng-Mayer C.
    Virology; 1997 Mar 17; 229(2):360-9. PubMed ID: 9126249
    [Abstract] [Full Text] [Related]

  • 6. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
    Posner MR, Elboim HS, Cannon T, Cavacini L, Hideshima T.
    AIDS Res Hum Retroviruses; 1992 May 17; 8(5):553-8. PubMed ID: 1381201
    [Abstract] [Full Text] [Related]

  • 7. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120.
    Posner MR, Cavacini LA, Emes CL, Power J, Byrn R.
    J Acquir Immune Defic Syndr (1988); 1993 Jan 17; 6(1):7-14. PubMed ID: 8417177
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.
    Fung MS, Sun CR, Liou RS, Gordon W, Chang NT, Chang TW, Sun NC.
    J Immunol; 1990 Oct 01; 145(7):2199-206. PubMed ID: 2398276
    [Abstract] [Full Text] [Related]

  • 9. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F, Bergami PL, Duval M, Kuhrt D, Posner M, Cavacini L.
    AIDS Res Hum Retroviruses; 2003 Jul 01; 19(7):597-607. PubMed ID: 12908937
    [Abstract] [Full Text] [Related]

  • 10. Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells.
    Clayton R, Ohagen A, Goethals O, Smets A, Van Loock M, Michiels L, Kennedy-Johnston E, Cunningham M, Jiang H, Bola S, Gutshall L, Gunn G, Del Vecchio A, Sarisky R, Hallenberger S, Hertogs K.
    J Virol Methods; 2007 Jan 01; 139(1):17-23. PubMed ID: 17034868
    [Abstract] [Full Text] [Related]

  • 11. Phase I study of a human monoclonal antibody directed against the CD4-binding site of HIV type 1 glycoprotein 120.
    Cavacini LA, Samore MH, Gambertoglio J, Jackson B, Duval M, Wisnewski A, Hammer S, Koziel C, Trapnell C, Posner MR.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):545-50. PubMed ID: 9591708
    [Abstract] [Full Text] [Related]

  • 12. Two new human monoclonal antibodies against HIV type 1 glycoprotein 120: characterization and neutralizing activities against HIV type 1 strains.
    Février M, Boudet F, Deslandres A, Theze J.
    AIDS Res Hum Retroviruses; 1995 Apr 01; 11(4):491-500. PubMed ID: 7543271
    [Abstract] [Full Text] [Related]

  • 13. Detection of T cell CD4 epitopes in HIV-infected individuals.
    Kunkl A, Valle MT, Fenoglio D, Dodi F, Morandi N, Rizzo F, Manca F.
    Eur J Histochem; 1994 Apr 01; 38 Suppl 1():41-6. PubMed ID: 8547709
    [Abstract] [Full Text] [Related]

  • 14. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120.
    Kang CY, Hariharan K, Posner MR, Nara P.
    J Immunol; 1993 Jul 01; 151(1):449-57. PubMed ID: 7686944
    [Abstract] [Full Text] [Related]

  • 15. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
    Briant L, Coudronnière N, Robert-Hebmann V, Benkirane M, Devaux C.
    J Immunol; 1996 May 15; 156(10):3994-4004. PubMed ID: 8621941
    [Abstract] [Full Text] [Related]

  • 16. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.
    Corbeau P, Benkirane M, Weil R, David C, Emiliani S, Olive D, Mawas C, Serre A, Devaux C.
    J Immunol; 1993 Jan 01; 150(1):290-301. PubMed ID: 7678031
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion.
    Burkly LC, Olson D, Shapiro R, Winkler G, Rosa JJ, Thomas DW, Williams C, Chisholm P.
    J Immunol; 1992 Sep 01; 149(5):1779-87. PubMed ID: 1380539
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody.
    Thali M, Olshevsky U, Furman C, Gabuzda D, Posner M, Sodroski J.
    J Virol; 1991 Nov 01; 65(11):6188-93. PubMed ID: 1717717
    [Abstract] [Full Text] [Related]

  • 19. Loss of serum antibodies to a conformational epitope of HIV-1/gp120 identified by a human monoclonal antibody is associated with disease progression.
    Cavacini LA, Emes CL, Power J, Underdahl J, Goldstein R, Mayer K, Posner MR.
    J Acquir Immune Defic Syndr (1988); 1993 Oct 01; 6(10):1093-102. PubMed ID: 7692037
    [Abstract] [Full Text] [Related]

  • 20. Plasma pharmacokinetics and biological activity of a human immunodeficiency virus type 1 neutralizing human monoclonal antibody, F105, in cynomolgus monkeys.
    Cavacini LA, Power J, Emes CL, Mace K, Treacy G, Posner MR.
    J Immunother Emphasis Tumor Immunol; 1994 May 01; 15(4):251-6. PubMed ID: 8061897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.